| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC38 |
| UNII: | R30772KCU0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Lymphocyte differentiation antigen CD38 inhibitor | PubMed |
| Primary Target | |
|---|---|
| CD38 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Multiple Myeloma | 4 | D009101 | FDA |
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Smoldering Multiple Myeloma | 2 | D000075122 | ClinicalTrials |
| Amyloidosis, Familial | 2 | D028226 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054198 | ClinicalTrials |
| Leukemia, T-Cell | 2 | D015458 | ClinicalTrials |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054218 | ClinicalTrials |
| Paraproteinemias | 2 | D010265 | ClinicalTrials |
| Anemia, Hemolytic, Autoimmune | 1 | D000744 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Immune System Diseases | 1 | D007154 | ClinicalTrials |
| Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1461640-62-9 |
| ChEMBL | CHEMBL3545131 |
| FDA SRS | R30772KCU0 |
| Guide to Pharmacology | 8719 |
CONTENTS